cancer clinical trials in kansas city, KS
|
Saint Luke's Cancer Institute at Saint Luke's Hospital
Kansas City, Kansas 66160-7330 Neuroblastoma
|
|
University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Head and Neck Squamous Cell Carcinoma
|
|
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Lung Cancer
|
|
University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Invasive Breast Cancer
|
|
Kansas City, Kansas 66160 Pain, Burning, Pain, Crushing, Pain, Migratory, Pain, Radiating, Pain, Splitting
|
|
University of Kansas Medical Center, Department of Neurology
Kansas City, Kansas Multiple Sclerosis, Relapsing-Remitting
|
|
University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Renal Cell Carcinoma
|
|
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Prostate Cancer
|
|
University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Acral Lentiginous Malignant Melanoma, Lentigo Maligna Malignant Melanoma, Mucosal Melanoma, Nodular Malignant Melanoma, Recurrent Melanoma, Stage IV Melanoma, Superficial Spreading Malignant Melanoma
|
|
GSK Investigational Site
Kansas City, Kansas 66160 Human Papillomavirus (HPV) Type 16/18 Infections, Cervical Neoplasia
|
|
University of Kansas Medical Center
Trial Locations University of Kansas Medical Center Providence Medical Center Kansas City Cancer Center-West Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
|
|
University of Kansas Cancer Center SC - Univ KS
Kansas City, Kansas 66160 Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia
|
|
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Trial Locations Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center Providence Medical Center Kansas City Cancer Centers - West Lung Cancer
|
|
University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
|
|
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Ovarian Cancer, Sarcoma
|
|
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Head and Neck Cancer
|
|
University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Gaucher Disease
|
|
Providence Medical Center
Kansas City, Kansas 66112 Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma
|
|
Kansas City, Kansas 66160 Castration-Resistant Prostate Cancer
|
|
University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Recurrent Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
|
|
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Cervical Cancer
|
|
ImClone Investigational Site
Kansas City, Kansas 66160 Non Small Cell Lung Cancer
|
|
University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Recurrent Uterine Sarcoma, Stage IIIA Uterine Sarcoma, Stage IIIB Uterine Sarcoma, Stage IIIC Uterine Sarcoma, Stage IVA Uterine Sarcoma, Stage IVB Uterine Sarcoma, Uterine Leiomyosarcoma
|
|
GSK Investigational Site
Kansas City, Kansas 66160 Lymphoma, Large-Cell, Diffuse
|
|
Providence Medical Center
Kansas City, Kansas 66112 Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer
|
|
University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Lymphoma
|
|
GSK Investigational Site
Kansas City, Kansas 66160 Leukaemia, Lymphocytic, Chronic
|
|
University Of Kansas
Kansas City, Kansas 66160 Breast Neoplasms, Breast Cancer, Breast Tumors
|
|
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Lung Cancer
|
|
University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
|
|
University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Smoking Cessation
|
|
University of Kansas Cancer Center
Kansas City, Kansas 66160 Pancreatic Cancer
|
|
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Cognitive/Functional Effects, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
|
|
Providence Medical Center
Kansas City, Kansas 66112 Burkitt Lymphoma, Diffuse Large B-cell Lymphoma, c-MYC Positive
|
|
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Cervical Cancer
|
|
Kansas City, Kansas 66160 Non-small Cell Lung Cancer
|
|
University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Smoking Cessation
|
|
University of Kansas Hospital
Kansas City, Kansas 66160 Chronic GVHD
|
|
Providence Medical Center
Kansas City, Kansas 66112 Lung Cancer
|
|
University of Kansas Hospital
Kansas City, Kansas 66160 Multiple Myeloma
|
|
University Of Kansas
Kansas City, Kansas 66160 Head and Neck Cancer
|
|
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Trial Locations Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center Kansas City Cancer Centers - West Kidney Cancer
|
|
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Trial Locations Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center Kansas City Cancer Centers - West Colorectal Cancer
|
|
University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
|
|
Kansas City Cancer Center
Kansas City, Kansas 66112 Soft Tissue Sarcoma
|
|
University of Kansas Medical Center
Trial Locations University of Kansas Medical Center University of Kansas Medical Center, Westwood Campus Malignant Lymphoma, Stem Cell Type, Autologous Transplant
|
|
University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Prostate Cancer
|
|
University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Renal Cell Cancer
|
|
GSK Investigational Site
Kansas City, Kansas 66160 Human Papillomavirus Infection, Cervical Neoplasia
|
|
GSK Investigational Site
Kansas City, Kansas 66160 Human Papillomavirus (HPV) Type 16/18 Infections, Cervical Neoplasia
|
|
University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Stage IB Esophageal Cancer, Stage IIA Esophageal Cancer, Stage IIB Esophageal Cancer, Stage IIIA Esophageal Cancer, Stage IIIB Esophageal Cancer
|
|
University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Ovarian Clear Cell Cystadenocarcinoma, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
|
|
Providence Medical Center
Kansas City, Kansas 66112 Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
|
|
Kansas City, Kansas 66160 Prostate Neoplasms, Genital Neoplasms, Male, Urogenital Neoplasms, Genital Diseases, Male
|
|
University of Kansas Cancer Center Univ of KS
Kansas City, Kansas 66160 Metastatic Renal Cell Carcinoma
|
|
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Trial Locations Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center Kansas City Cancer Centers - West Prostate Cancer
|
